omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TP039<br />
Patrick Goertz<br />
University of Texas at Austin<br />
Institute <strong>for</strong> Cellular <strong>and</strong> Molecular Biology<br />
1 University Station A4800<br />
Austin, Texas 78712-0159<br />
goertz.p@mail.utexas.edu<br />
Automated Selection of Aminoglycoside Antibiotic Aptamers<br />
165<br />
Co-Author(s)<br />
J. Colin Cox<br />
Andrew D. Ellington<br />
The in vitro selection of aptamers that bind to low molecular weight targets is commonly a tedious, timeconsuming<br />
project. Aptamers are short (~80 nt) segments of nucleic acid that have been shown to mimic many<br />
properties of antibodies <strong>and</strong> which bind with high specificity <strong>and</strong> affinity to molecular targets. The process of<br />
selecting aptamers includes several rounds of combining the target with a r<strong>and</strong>omized pool of nucleic acid,<br />
washing away the non-binding species, <strong>and</strong> amplifying the bound me<strong>mbers</strong>. Subsequent iterations of this process<br />
narrow down the nucleic acid pool to the strongest binding species. We have exp<strong>and</strong>ed current automated<br />
selection protocols to include aptamer selections against small molecules including the aminoglycoside antibiotic<br />
neomycin. This modified procedure decreases both the frequency of manual h<strong>and</strong>ling of the selection reagents<br />
<strong>and</strong> the time required to per<strong>for</strong>m the experiment generating aptamers against the chosen target at a much greater<br />
rate. The method is suitable <strong>for</strong> integration with high throughput technologies, greatly exp<strong>and</strong>ing the possibility<br />
of discovering useful aptamers against other low weight targets. Such targets could include those with important<br />
diagnostic value such as neurotransmitters.<br />
TP040<br />
Norbert Gottschlich<br />
Greiner Bio-One, Inc.<br />
Maybachstrasse 2<br />
Frickenhausen72636 Germany<br />
norbert.gottschlich@gbo.com<br />
Mass Production of Plastic Chips <strong>for</strong> Microfluidic Applications<br />
Co-Author(s)<br />
A. Gerlach, G. Knebel,<br />
W. Hoffmann, A. E. Guber,<br />
Forschungszentrum Karlsruhe,<br />
Institut für Mikrostrukturtechnik<br />
Germany<br />
Commonly, microfluidic chips <strong>for</strong> medical diagnostics or life sciences are made from glass or silicon. Over the last<br />
years, however, polymers have gained great interest as substrates since they promise lower manufacturing costs.<br />
In addition, polymers are available with a wide range of excellent physical <strong>and</strong> chemical properties. For a low-cost<br />
production of microfluidic systems as single-use products, adequate manufacturing techniques are required. We<br />
have produced several microfluidic systems from various plastic materials, mainly <strong>for</strong> Capillary Electrophoresis<br />
(CE). The microchannel systems were either molded into the plastic substrate by vacuum hot embossing or<br />
produced by optimized injection molding. Routinely, mechanical micromachining was used to create the required<br />
metal molding tools. Extremely precise mold inserts could be generated by galvanic/lithographic processes.<br />
The CE chips have been used to separate both DNA fragments <strong>and</strong> mixtures of inorganic ions. Detection was<br />
carried out either by laser induced fluorescence (LIF) or by electrical methods. In the latter case, contact-free<br />
conductivity detection with electrodes located outside of the CE system was used. Microstructures have also been<br />
incorporated in a larger <strong>for</strong>mat that meets the st<strong>and</strong>ardized microplate footprint commonly used in high throughput<br />
screening (HTS). Microfluidic plates with 96 or 384 identical microstructures <strong>for</strong> applications in HTS, clinical<br />
diagnostics, <strong>and</strong> gene analysis have been manufactured as well.<br />
POSTER ABSTRACTS